Publications by authors named "Victor Gian"

Claim this Profile
E
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
David R Spigel, Howard A Burris, F Anthony Greco, Kent C Shih, Victor G Gian

Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
David R Spigel, Mark S Rubin, Victor G Gian, Dianna L Shipley, Howard A Burris

Lung Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.
Johanna C Bendell, Ahmed Zakari, James D Peyton, Ralph Boccia, Mark Moskowitz, Victor Gian

Oncologist· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.
John D Hainsworth, Dana S Thompson, John A Bismayer, Victor G Gian, William M Merritt

Cancer Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
David R Spigel, F Anthony Greco, David M Waterhouse, Dianna L Shipley, John D Zubkus, Victor G Gian

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancer.
David R Spigel, John D Hainsworth, Jitendra G Gandhi, Victor G Gian, James D Peyton

J Thorac Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I trial of protracted oral fixed-dose temozolomide.
Suzanne F Jones, F Anthony Greco, Victor G Gian, Fernando T Miranda, Eric L Raefsky

Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
Borje S Andersson, Ashwin Kashyap, Victor Gian, John R Wingard, Hugo Fernandez

Biol Blood Marrow Transplant· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Suzanne F Jones, Victor G Gian, F Anthony Greco, Fernando T Miranda, Dianna L Shipley

Oncology (Williston Park)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients.
John D Hainsworth, Mark G Mainwaring, Melodie Thomas, Lester L Porter, Victor G Gian

Clin Lung Cancer· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis